2HQ-12559-07198
2 vaccinations
2 coded responses
24 check-ins
2 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 12-15
- ZIP prefix
- 263 / WV
- Registered
- 2021-07-26
- Relationship
- Child or adolescent in my care
- Guardian
- EBR-19950-55037
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-26
Registered in v-safe
-
2021-07-26
Dose 1 — Pfizer-BioNTech
- 2021-07-26
-
2021-07-27
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · NoneAdult check-in
-
2021-07-28
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · NoneAdult check-in
-
2021-07-29
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-07-30
- 2021-07-31
- 2021-08-02
- 2021-08-09
-
2021-08-16
Dose 2 — Pfizer-BioNTech
- 2021-08-16
-
2021-08-17
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Poor · Site: Pain · Fever · Chills, Fatigue or tiredness, Nausea, Vomiting, Abdominal pain · Be unable to do their normal daily activitiesAdult check-in
-
2021-08-18
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-08-19
- 2021-08-20
- 2021-08-21
- 2021-08-22
- 2021-08-24
- 2021-08-30
- 2021-09-06
- 2021-09-13
- 2021-09-20
- 2021-09-28
-
2021-11-16
Survey response — 3 months, dose 2, dependentMedDRA: Epistaxis, Medical counselling — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Random nosebleeds that feel as if his nose is runny. Has had 3 within a two week time frame that eventually stopped after a period of 30 minutes. · Healthcare visit (other): School health nurseMedDRA releases: 2024-11 · check-in free text available
-
2021-11-16
Report sent to call center — 3 months, dose 2, dependentGet care from a doctor or other healthcare professional1 call case(s)
- 2021-12-01
- 2022-02-14
-
2022-08-16
Survey response — 12 months, dose 2, dependentMedDRA: Anxiety, Depression — Feeling: GoodFree text: Depression and anxietyMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-26 | Pfizer-BioNTech | No |
| 2 | 2021-08-16 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — 3 months, dose 2, dependent
Symptoms: Random nosebleeds that feel as if his nose is runny. Has had 3 within a two week time frame that eventually stopped after a period of 30 minutes.
Healthcare visit (other): School health nurse
Release 12 — 12 months, dose 2, dependent
Symptoms: Depression and anxiety
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| SD | Anxiety | · | · | ✓ |
| SD | Depression | · | · | ✓ |
| SD | Epistaxis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release